![]() |
|
|
Vol. 290, Issue 2, 535-542, August 1999
Department of Pharmacology, Pavlov Medical University, St.
Petersburg, Russia (A.K., E.Z.); and Section of Molecular
Neuropharmacology, Department of Physiology and Pharmacology,
Karolinska Institute, Stockholm, Sweden (A.K., B.J., B.B.F.)
Drug-naive DBA/2 mice were trained to self-administer cocaine (40 µg/kg/infusion) i.v. by nose poking. The number of nose-poke responses was higher in mice receiving response-contingent injections of cocaine (active group) than in yoked controls or in animals receiving response-contingent saline injections. Twenty-four hours after the training session (cocaine or saline self-administration), mice were injected i.p. with saline, cocaine, caffeine,
1,3-dipropyl-8-cyclopentyl xanthine (DPCPX), 8-cyclopentyl theophylline
(8-CPT),
5-amino-7-(2-phenylethyl)2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine (SCH
58261), or
9-chloro-2(2-furyl)[1,2,4]triazolo[1,5-c]quinazolin-5-amine (CGS 15943) and placed again in exactly the same operant boxes as
during the training session but without response-contingent i.v.
infusions. Saline injection elicited similar responding in animals from
the active group and from the yoked control group. A low dose of
cocaine (5 mg/kg) or caffeine (3 mg/kg), but not higher doses, produced
greater responding in the active group than in the yoked control group
during a single extinction trial. The adenosine A1-receptor
antagonists DPCPX and 8-CPT and the nonselective antagonist CGS 15943 partially reproduced the effect of a low dose of caffeine on the
cocaine-associated behavior in a dose-dependent manner and did not
alter the nose-poke activity of yoked control mice in the extinction
experiment. In contrast, the adenosine A2A antagonist SCH
58261, in doses above 1 mg/kg, reduced nose-poke activity equally in
active and yoked control animals. This confirms that a drug from a
different pharmacological class (adenosine-receptor antagonist) can
induce behavior changes similar to the effects of the original
self-administered drug (indirect dopamine-receptor agonist). The data
also suggest that the effects of caffeine on cocaine-seeking behavior
might be related to interaction with adenosine A1
receptors, but not A2A receptors.